Keywords: canada, joins, europe, tasmar, suspension, therapeutic, products

Canada Joins Europe In Tasmar Suspension

Article | 25 November 1998

The Therapeutic Products Directorate of Health Canada has suspended thesale of Roche's Tasmar (tolcapone), used in the treatment of Parkinson's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Tasmar

Tolcapone

Go to drug listing